A new CRISPR-based one-off procedure that lowers "bad" cholesterol is expected to enter Phase I human trial in 2026. If successful, it could be the first approved genetic-silencing method on the ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

Scientists at The University of Texas at Austin have developed a revolutionary gene-editing method using bacterial retrons that can correct multiple disease-causing mutations at once. Unlike ...

Eli Lilly & Co. struck a deal worth more than $1.1 billion with German biotech Seamless Therapeutics GmbH to develop gene therapies for hearing loss. Closely-held Seamless will design a type of enzyme ...

Eli Lilly is continuing a run of dealmaking to strengthen its genetic medicine offering by penning a pact with gene editing company Seamless Therapeutics. This morning’s deal with Seamless centers on ...

Big Four firm PwC announced a new formalized engineering career path, offering a dedicated avenue for advancement based on technology skills and leadership. Processing Content "Engineers are central ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. New gene therapies such as AMT‑130 are beginning to slow Huntington’s disease progression, ...

AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely a mystery. By Carl Zimmer In 2024, two scientists from Google DeepMind ...

An engineering company has expanded into Pennsylvania as a result of an acquisition. VHB acquired Drive Engineering, a 16-year-old transportation engineering firm, with offices in East Pennsboro ...

Less than a year after Hollywood icon Gene Hackman and his wife, Betsy Arakawa, were found dead inside their secluded Santa Fe compound, the storied property is already moving toward a sale. The ...

Part of a USD 23 billion US investment to expand R&D and advanced manufacturing to reach more patients East Hanover, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global ...